Las...abandonan el barco. Ahora es Elmar Schnee, head of Merck KGaA’s/Serono

Elmar Schnee, head of Merck KGaA’s pharmaceuticals unit, is stepping down to be replaced by the boss of emerging markets at US drugs giant Merck & Co.

Mr Schnee, born in 1959, is leaving for personal reasons as chief of Merck Serono, and Stefan Oschmann, 53, (en la foto) will take over the unit as well as the Darmstadt-based group’s Consumer Health Care division from January 1. The latter, a German, had been with Merck & Co since 1989 and has served as president of emerging markets since 2009.

The announcement came hours after the Financial Times Deutschland had reported that Merck would not be extending Mr Schnee’s contract due in part to the clinical setbacks the firm has suffered of late. Last month, the US Food and Drug Administration extended its review period for the company’s multiple sclerosis pill cladribine, which was rejected by advisors to the European Medicines Agency in September.

Más